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Edited by AR NdhlalaObjective: To ascertain various phytochemical ingredients in Ximenia americana leaves extracts by GC-MS &
evaluating their antidiabetic property by using in vitro assays.
Methods: The serial extraction was carried out with a series of solvents: chloroform, ethyl acetate, methanol,
ethanol and water with increasing polarity using Soxhlet apparatus. The concentrated and dried extracts were
subjected to GC-MS analysis and also the antidiabetic activity was assessed by employing standard in vitro
techniques.
Results: GC-MS analysis conﬁrmed the presence of different phytochemicals in each leaf extracts of X. americana.
The major phytoconstituents were found to be Oleic acid, n-Hexadecanoic acid, Non-decanoic acid and
Octadecatrienoic acid in chloroform extract; and 3-Undecene, Tridecene, Triﬂuoroaceteoxy tetradecene,
and Trichloroacetic acid-3-tridecyl-ester in ethyl acetate extract; where in 1-Tetracosanol, Behenyl alcohol,
1-Hexacosanol, Octadecanal, 4-Piperidine propanoic acid and α –D-mannofuranoside in methanol extract;
8,11,14-Eicosatrienoic acid, 7-Tetradecanal and 1-Ocytyn-3-Ol-4-Ethy in ethanol extract; aqueous extract
showed the presence of 9,12-Octadecandionoic acid. In vitro antidiabetic studies show that aqueous extract
exhibited signiﬁcant activity when compared to other solvent extracts.
Conclusion: The investigation conﬁrms that aqueous extract exhibited highest antidiabetic activity among all
extracts; Additional studies on needed for puriﬁcation, characterization and structural elucidation of bioac-
tive compounds from aqueous extract & also conﬁrm its antidiabetic property by in vivo studies. This study
provides scientiﬁc evidence that leaves of Ximenia americana have anti-diabetic efﬁcacy. Thus, considering
its relative hypoglycemic potency, they may serve as useful therapeutic agents for treating diabetes.
© 2017 SAAB. Published by Elsevier B.V. All rights reserved.Keywords:
Ximenia americana
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in vitro antidiabetic activity
GC-MS1. Introduction
Diabetes mellitus is affecting around 25% of the world population of
both developed and developing countries (Kayarohanam and Kavimani,
2015; Benalla et al., 2010; Rahimi, 2015). China was the country with
the highest number of diabetics worldwide, with some estimated 110
million persons, followed by India (70million) and USA (30million) suf-
fering from diabetes. WHO projects that diabetes will be the 7th leading
cause of death in 2030. Diabetes with cardiovascular complications im-
poses a major threat on human health claiming death in every 10 s
(Das & Rai, 2008). Diabetes cases are exponentially increasing in India
as a result of societal inﬂuence and life styles (Gupta andMisra, 2007). Di-
abetesmellitus is considered as the group ofmetabolic disorderswith dif-
ferent causes, which are characterized by imbalancing in carbohydrates,
proteins and fat metabolism that lead to the effect on insulin action orurthy).
ghts reserved.secretion (American Diabetes Association, 2007). In modern medicine
there is still no reasonable effective therapy or drug to cure diabetes
(Ali et al., 2006). The currently accessible anti-diabetic agents include sul-
fonylureas, thiazolidinedione, α-glycosidase inhibitors such as miglitol
and acarbose widely used to control hyperglycemia. Nevertheless, these
drugs fail to cure the disease in addition, causes several diabetic compli-
cations and side effects such as abdominal pain, diarrhea and soft feces
in colon (Ahmed et al., 2004; Davis and Granner, 2001).
Plant families are considered to be a source for the most potent hy-
poglycemic properties (Patel et al., 2012a; Patel et al., 2012b). The
drugs from plant sources are usually considered to be non-toxic with
lesser side effects than synthetic drugs. Traditional medicinal plants
having anti-diabetic properties can provide useful sources for the dis-
covery of safer hypoglycemic agents (Sunila et al., 2012). These plants
are the major source for discovering new compounds with therapeutic
value for drug development against most common and very prevalent
disease, diabetes mellitus. The plants which have therapeutic applica-
tion possess bioactive composites viz., alkaloids, glycosides, tannins, ﬂa-
vonoids, saponins, phenolics and vitamins. (Ghani, 2003). Different
203A.K. Shettar et al. / South African Journal of Botany 111 (2017) 202–211parts of plants vary in their composition of bioactive compounds and
also medicinal properties (Harbone, 2006). Chemical compounds
that are often referred as secondarymetabolites are the phytochemicals
formed in the plants during normalmetabolic processes (Mallikharjuna
et al., 2007). These secondary metabolites are an important source with
a variety of structural arrangements and properties (De-Fatima et al.,
2006). In ancient Indian literaturemedicinal properties of several herbal
plants have been documented and the preparations have been found to5.0 7.5 10.0 12.5 15.
1.0
2.0
3.0
4.0
5.0
6.0
7.0
(x1,000,000)
TIC
14
.1
08
50.0 75.0 100.0 125.0 150
0
100
%
43
60 73
83 12979 11513
50 100 150
0
100
%
41 55
67 79 95 109 123 94113 731
50 100 150
0
100
%
41
55 7967
95 108 121 135 14913 61
50 100 150
0
100
%
43
55 73
83 12997 111 14313 157
50 100 150
0
100
%
41
55
69 83 97 111 125 93113 151
Fig. 1. GC Chromatogram of Chloroformbe effective in treatment of diseases. Therefore, to come across the de-
mand of manufacturing modern medicines and export, the need of the
medicinal plants have enormously ampliﬁed (Prashanth et al., 2006).
The ethnobotanical statistics reports about 1200 odd plants thatmay
possess antidiabetic potential worldwide (Arumugam et al., 2013;
Bnouham et al., 2006; Wadkar et al., 2008; Tundis et al., 2010). In the
present study Ximenia americana Linn. plant belonging to Olacaceae
family was selected. X. americana is a small tree or shrub, native to0 17.5 20.0 22.5
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leaf extract of Ximenia americana.
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This species is used in treatment of wide variety of ailments by many
rural communities in Africa and Asia. This is commonly known as wild
olive or sour plum or yellow plum and extensively used as herbal rem-
edy in treatment of malaria, leproutic ulcer, and skin infections (Voss
et al., n.d.). The leaves are reported to have antibacterial activity and
also used in the treatment of fever, tuberculosis, tooth decay and
wounds (Ogunyleye & Ibitoye, 2003).Many investigations has validated
the use of roots in the treatment of leprosy, syphilis, dysentery, and
wounds. The stem bark has been reported to have anti-trypanosmal ac-
tivity. The root bark and leaf of Ximenia americana is used as herbal
medication for the cure of many ailments by Northern part of Nigeria
(Maikai et al., 2008a; Maikai et al., 2008b). In our previous studies the
aqueous andmethanolic leaf extracts of X. americana showed signiﬁcant
antioxidant and anti-inﬂammatory activities (Arun et al., 2015). How-
ever, till-date a systematic study on biological activities of chemical con-
stituents present in X. americana is still not agreeable (Monte et al.,
2012; James et al., 2007). The extensive literature survey exposed that5.0 7.5 10.0 12.5 15.0
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Fig. 2. GC Chromatogram of Ethyl acetatonly few reports exist on this plant leaves, but no information are avail-
able on anti-diabetic activity in particular. Henceforth, present study
was aimed to explore the phytochemical constituents of Ximenia
americana by Gas Chromatography-Mass Spectrometry (GC-MS) analy-
sis and also evaluating the in vitro anti-diabetic activity of the different
solvent extracts.
2. Materials and methods
2.1. Plant collection
Ximenia americana leaves were collected from Karnatak University
Campus, Dharwad, India in the month of June, 2014. The leaves were
identiﬁed and authenticated by Dr. Kotresha K., Department of Botany,
Karnatak Science College, Dharwad, Karnataka, India. A voucher speci-
men (N0-01/2016) was deposited at the Department of Botany,
Karnatak Science College, Dharwad, Karnataka. Fresh disease free
plant material was washed under running tap water, shade dried and17.5 20.0 22.5
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Fig. 2 (continued).
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stored in airtight containers at room temperature for further use.
2.2. Crude extraction
The 100 g of dried X. americana leaf material was extracted with
chloroform using Soxhlet apparatus for 4–6 h at 40–50 °C. The extract-
ant solvent was evaporated using rotary evaporator and the resultant
slurry of crude extract was thoroughly dried and weighed. The extract
was freeze-dried at −20 °C and stored at 4 °C until use. Similarly,
ethyl acetate, methanol, ethanol and water extracts were obtained.
The yield was found to be 4, 5, 3.7, 4 and 8% w/w respectively with ref-
erence to the air dried plant material. All extracts were concentrated in
desiccator and subjected to GC-MS analysis.
2.3. GC-MS proﬁling of Ximenia americana extracts
GC-MSmodel GCMS-QP2010Swas used in the analysis that employs
fused silica column and the components were separated using helium
as a carrier gas at a constant ﬂow of 1 ml/min. The 1 μl sample extract
was injected into the instrument. The initial temperature was set at
100 °C,whereas the injector temperaturewas set at 250 °C and through-
out the process temperature ﬂow was set at the speed of increasing 10
°C/min. The actual separation was observed at 24th minute, for which
ﬁnal temperature was adjusted to 280 °C and run for 5 min
(Gopalakrishnan & Vadivel, 2011).
2.4. Mass spectral interpretation and identiﬁcation of compounds
Identiﬁcation of the compounds was done based on comparison
with library spectra data bases of National Institute of Standard andTechnology (NIST). The spectrum of the unknown component was
compared with spectrum of known components stored in the NIST
library. The structure of components in the test materials were
identiﬁed based on the molecular weight. The name, molecular for-
mula, molecular weight, compound nature of test material was
identiﬁed based on literature and NIST library (Kirtikar and Basu,
2001; Davies, 1990). Biological activity of all identiﬁed compounds
was identiﬁed by literature survey and Dr. Duke's Phytochemical
and Ethno botanical Databases (Dr. Duke's Phytochemical and
Ethnobotanical Databases).
2.5. Evaluation of antidiabetic activity by using in vitro assays
2.5.1. Alpha-amylase inhibitory assay
The Alpha-amylase inhibitory assay of methanol and aqueous
extracts of X. americana was evaluated according to a previously de-
scribed method by Ranilla et al. (2008) with slight modiﬁcation (Lena
Galvez Ranilla et al., 2008). In brief, 0.5 ml of extract was mixed with
0.5 ml of α-amylase solution (0.5 mg/ml) with 0.02 M sodium
phosphate buffer (pH 6.9 with 0.006MNaCl). Themixturewas incubat-
ed at room temperature for 10min and 0.5 ml of starch solution (1%) in
0.02M sodiumphosphate buffer (pH6.9with 0.006MNaCl)was added.
The resulting mixture was incubated at room temperature for 10 min,
and the reaction was terminated using 1 ml of dinitrosalicylic acid
color reagent. At this time, the test tubes were placed in a water bath
(100 °C for 5 min) and cooled until room temperature was attained.
Themixturewas then dilutedwith 10ml of deionizedwater, and absor-
bance was determined at 540 nm. The absorbance of blank (buffer
instead of extract and amylase solution) and control (buffer instead of
extract) samples were also determined. Acarbose was used as standard
drug. The inhibition of α-amylase was calculated using the following
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Fig. 3. GC Chromatogram of Methanol leaf extract of Ximenia americana.
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% inhibition of α−Amylase ¼ Abscontrol−Abssample
 
= Abscontrolð Þ  100where Abscontrol corresponds to the absorbance of the solution without
extract (buffer instead of extract) and with α -amylase solution and
Abssample corresponds to the solution with extract and α -amylase
solution.
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Fig. 4. GC Chromatogram of Ethanol leaf extract of Ximenia americana.
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Fig. 5. GC Chromatogram of Aqueous leaf extract of Ximenia americana.
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Glucose uptake assay by yeast cells was performed according to
Cirillo et al. (1963) (Cirillo et al., 1963). The yeast, Saccharomyces
cerevisiae suspended in distilledwaterwas subjected to repeated centri-
fugation (3000 ×g, 5 min) until clear supernatant ﬂuids were obtained
and 10% (v/v) of the suspensionwas prepared in distilledwater. VariousTable 1
Phytochemical compounds identiﬁed in the chloroform extract of Ximenia americana using GC
Sl. no. Compound name Molecular
formula
Molecular
weight
Retention
time
Peak
area
Similarity
index
1. Oleic acid C18H34O2 282 15.791 45.64 95%
2. n-Hexadecanoic acid C16H32O2 256 14.108 35.29 93%
3. Non-decanoic acid C19H38O2 298 15.836 11.21 91%
4. Octadecatrienoic acid C18H30O2 278 15.947 7.86 90%concentrations of plant extracts (50 to 250 μg/ml)were added to 1ml of
glucose solution (5mM) and incubated together for 10min at 37 °C. Re-
action was started by adding 100 μl of yeast suspension followed by
vortexing and further incubation at 37 °C for 60 min. After 60 min, the
tubes were centrifuged (2500 ×g, 5 min) and amount of glucose was
estimated in the supernatant. Metronidazole was used as standardMS.
Compound nature Uses
Monounsaturated fatty acid Anti-oxidant and anti-Breast cancer.
Saturated fatty acid Cosmetic, anti-oxidant, anti-bacteria and anti-fungal.
Fatty acid Dietary nutrient, anti-inﬂammatory, Biomarker for
Prostate cancer.
Fatty acid Dietary nutrient and anti-inﬂammatory.
Table 2
GC–MS analysis of phytochemical compounds in the Ethyl acetate extract of Ximenia americana.
Sl. no. Compound name Molecular
formula
Molecular
weight
Retention
time
Peak area Similarity
index
Compound
nature
Uses
1. 3-Undecene C11H22 154 7.57 3.34 92% – –
2. Tridecene C13H26 182 9.987 4.65 91% Fatty acid Respiratory irritations.
3. Triﬂuoroaceteoxy tetradecene C16H29F3O2 310 14.050 8.24 89% – –
4. Trans-11Tetradecenylacetate C16H30O2 254 12.712 5.42 87% – –
5. Trichloroacetic acid-3-tridecyl-ester C15H27Cl3O 344 12.208 4.03 87% – –
Table 3
Compound identiﬁed in the methanol extract of Ximenia americana using GCMS.
Sl. no. Compound name Molecular
formula
Molecular
weight
Retention
time
Peak
area
Similarity
index
Compound nature Uses
1. 1-Tetracosanol C24H50O 354 5.223 13.42 93% Fatty acid alcohol –
2. Behenyl alcohol C22H46O 326 12.001 73.34 92% Saturated fatty alcohol Anti-viral agent (Herpes simples virus)
3. 1-Hexacosanol C26H54O 382 14.041 5.21 91% Saturated fatty alcohol Wax and Polymer
4. Octadecanal C18H36O 268 15.445 0.69 90% Long chain aldehyde Pheromone
5. 4-Piperidine propanoic acid C19H26ClNO 351 15.727 4.27 89% – –
6. α –D-mannofuranoside C7H14O6 194 15.783 2.63 86% Carbohydrate Thickening agent, plasticizer, and resins.
208 A.K. Shettar et al. / South African Journal of Botany 111 (2017) 202–211drug. The percentage increase in glucose uptake by yeast cells was cal-
culated using the following formula:
Increase in glucose uptake %ð Þ ¼ Abssample−Abscontrol
Abssample
 100
where, Abs sample is the absorbance of test sample and Abs control is the
absorbance of control reaction (containing all reagents except the test
sample). All the experiments were carried out in triplicates.
2.6. Statistical analysis
All experiments were performed in triplicates (n = 3) and the data
are presented as the mean ± standard error. Differences between the
means of the individual groups were analyzed using the analysis of var-
iance procedure of SPSS software Version 20 (IBM). The signiﬁcance of
differences was deﬁned at the p b 0.05 and p b 0.01 level.
3. Results
3.1. GC-MS result
The results pertaining to GC-MS analysis (Figs. 1–5) revealed the
identity of four major compounds present in chloroform extract, ﬁve
in the ethyl acetate extract, six in the methanol extract, three in the
ethanol extract, and only one in the aqueous extract of Ximenia
americana leaves. These compounds were identiﬁed through mass
spectra generated by mass spectrometry connected to GC. The various
compounds present in the leaf of X. americana were detected by the
GC-MS as shown in Tables 1–5.
3.2. Alpha-amylase inhibitory assay
The different solvent extracts of X. americana were subjected to α-
amylase inhibitory assay along with Metronidazole as a standard. TheTable 4
Compound identiﬁed in the Ethanol extract of Ximenia americana using GCMS.
Sl. no. Compound name Molecular
formula
Molecular
weight
Retention
time
Peak
area
1. 8,11,14-Eicosatrienoic acid C20H34O2 306 14.048 30.1
2. 7-Tetradecanal C14H26O 210 15.737 69.0
3. 1-Ocytyn-3-Ol-4-Ethy C10H18O 154 15.783 0.80aqueous extract showed higher activity among all other extracts tested
(Fig. 6), whichwas comparable to standard acarbose. Theα-amylase in-
hibitory activities of differed solvent extracts are recorded in Table 6.
3.3. Glucose uptake in yeast cells
Different concentrations of X. americana leaves solvent extracts are
subjected to in vitro glucose uptake assay employing yeast as model.
The percentage of glucose uptake in yeast cells by the extract was com-
pared with standard drug metronidazole. Aqueous extract exhibited
higher activity than the remaining solvent extracts tested (Fig. 7).
There was concentration dependent increase in percentage of glucose
uptake with increasing in concentration of X. americana extract
(Table 7). Among all the extracts studies, aqueous extract exhibited
highest percentage of glucose uptake i.e. 67.08 ± 0.499, which was
almost near to the standard i.e. 68.06 ± 0.496 (Fig. 7) at 250 μg concen-
tration. Results also indicated that X. americana had almost same efﬁ-
ciency in increasing the glucose uptake by yeast cells as compared to
standard drug metronidazole.
4. Discussion
Diabetes mellitus is a non-communicable disease often genetic in
nature but can be developed due to the life style. In modern medicine
there is no acceptable effective therapy or medication to treat diabetes
(Ali et al., 2006). Medicinal plants having anti-diabetic properties can
provide a useful source for the unearthing of safer economic anti-
diabetic drug. Recent extensive review by Benalla et al. (2010) listed
47 species that belong to 29 plant families as a source of alpha glucosi-
dase inhibitors (Benalla et al., 2010), but X. americanawas not listed. In
the present research investigation different solvent extracts of
X. americana are evaluated for their anti-diabetic activity. Two different
in vitro assays were used to evaluate anti-diabetic activities of different
solvent extracts of X. americana viz., alpha-amylase and glucose uptake
assay.Similarity
index
Compound nature Uses
8 92% Polyunsaturated fatty acid Prostaglandins
2 89% Alcohol Alcohol Industry
81% Ester Perfume ﬂavor and Food additives
Table 5
Compound identiﬁed in the aqueous (water) extract of Ximenia americana using GCMS.
Sl. no. Compound name Molecular
formula
Molecular
weight
Retention
time
Peak
area
Similarity
index
Compound nature Uses
1. 9,12-Octadecandionoic acid C18H32O2 280 21.658 100 86% Poly-unsaturated fatty acid Anti-oxidant, surfactant and Oil paints
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tant role in carbohydrate digestion and glucose absorption. Suppression
of the activity of digestive enzymes such asα-amylase, would delay the
digestion of starch and oligosaccharides,which in turn decreases the ab-
sorption of glucose and consequently reduce the blood glucose (Puls
et al., 1997). Aqueous extract of X. americana exhibited highest percent-
age of inhibition i.e. 51.94 ± 0.265 (Fig. 6). This signiﬁcant anti-diabetic
activity was comparable to the standard drug inhibition. This technique
is one of the anti-diabetic therapeutic approaches to reduce the post
prandial glucose level in blood by inhibiting activity of alpha-amylase
enzyme and it can be used as a strategy in management of blood
glucose.
Regulation of glucose level in the blood of diabetic patient can
prevent numerous complications associatedwith thedisease. Themain-
tenance of plasma glucose concentration for longer timeunder variation
in dietary condition is one of the most important and closely regulated
processes observed in the mammalian species (Ammayappan et al.,
2012), especially type II diabetes characterized by deﬁciency of insulin
causing increased level in blood glucose level and it depends on the up-
take of glucose by the cells (Shori, 2015). In the present study, different
solvent extracts of X. americana were subjected to in vitro anti-diabetic
assay by means of yeast as model. Percentage of increase in glucose up-
take in yeast cells by the action of X. americana extracts was compared
with the standard drug metronidazole. The increased concentration of
extracts correspondingly increased percentage of glucose uptake in
yeast cells. This result indicated that high concentrations of extracts ex-
hibited high glucose uptake.
Plants are the major source for discovering new compounds with
medicinal value for drug development (Bnouham et al., 2006; Wadkar
et al., 2008; Tundis et al., 2010 and Shori, 2015). In chromatography
methods, gas chromatography (GC) is one of the most widely used
techniques and has become one of the most important tools for the
separation of phytocompounds. In the last few years GC-MShas become
ﬁrmly established itself as a powerful technique for identiﬁcation of
secondary metabolites in both plant and non-plant species (SharmaCE: Chloroform extract, EAE: Ethyl acetate ex
AE: Aqueous extract, STD: 
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Fig. 6. Percentage inhibition ofα-amylase by Ximenia americana leaf extracts CE: Chloroform exand Vijayvergia, 2015; Robertson, 2005; Fernie et al., 2004; Kell et al.,
2005). In the present study different solvent extracts of X. americana
viz., chloroform, ethyl acetate, methanol, ethanol and aqueous extracts
were subjected to GC-MS analysis. GC-MS spectrum conﬁrms the pres-
ence of various bioactive compounds in all extracts of X. americanawith
different retention time. The gas chromatogram shows presence of
relative concentration of various compounds present in X. americana
getting eluted at different retention time (Hema et al., 2011a; Praveen
et al., 2010; Maruthupandian and Mohan, 2011; Grover et al., 2002;
Hema et al., 2011b). The peak height represents relative concentration
of components present in Ximenia americana. The mass spectrometer
helps in the identiﬁcation of compounds eluted at different retention
time (Figs. 1–5). The major phytoconstituents were found to be Oleic
acid, n-Hexadecanoic acid, Non-decanoic acid and Octadecatrienoic
acid in chloroform extract; and 3-Undecene, Tridecene, Triﬂuoro-
aceteoxy tetradecene, Trans-11Tetradecenylacetate and Trichloroacetic
acid-3-tridecyl-ester in ethyl acetate extract; where in 1-Tetracosanol,
Behenyl alcohol, 1-Hexacosanol, Octadecanal, 4-Piperidine propanoic
acid and α –D-mannofuranoside in methanol extract; 8,11,14-
Eicosatrienoic acid, 7-Tetradecanal and 1-Ocytyn-3-Ol-4-Ethy in
ethanol extract; aqueous extract showed the presence of 9,12-
Octadecandionoic acid. The above mentioned identiﬁed compounds
are known to possess several biological activities and industrial
applications such as n-Hexadecanoic acid was known to have
antioxidant, anti-inﬂammatory, hypocholesterolemic and cancer
prevention activities (Kalpana et al., 2012); tetradecanoic acid was
known to have antibacterial and antifungal activity (Agoramoorthy
et al., 2007); 9,12-Octadecandionoic acid was reported to have anti-
inﬂammatory, antibacterial, hypocholesterolemic and hepatoprotec-
tive activity (Sermakkani & Thangapandian, 2012); oleic acid was
proven to having antibacterial activity and industrial application as
emulsifying agent (Smolinske & Susan, 1992). Overall these
phytoconstituents have been shown to possess different biological
activities and industrial applications such as antioxidant, anti-
inﬂammatory, antiviral, antibacterial, antifungal, dietary nutrient,tract, ME: Methanol extract 
Acarbose.
/ml 100µg/ml 100µg/ml
AE STD
americana extracts 
Inhibition (I %)
tract, EAE: Ethyl acetate extract, ME:Methanol extract AE: Aqueous extract, STD: Acarbose.
Table 6
α-Amylase inhibitory activities and IC50 values by Ximenia americana extracts.
Samples Concentration Inhibition (I %) IC50 (μg/ml)
Chloroform 100 μg/ml 29.66 ± 0.665 168.57 μg
Ethyl acetate 100 μg/ml 28.14 ± 0.528 177.08 μg
Methanol 100 μg/ml 47.51567 ± 0.077 105 μg
Ethanol 100 μg/ml 39.07 ± 0.549 128 μg
Aqueous 100 μg/ml 51.94 ± 0.265 96.26 μg
Standard (acarbose) 100 μg/ml 59.11 ± 0.402 84.58 μg
Table 7
Percentage of glucose uptake in yeast cells treated with Ximenia americana extracts.
Samples Concentration(μg/ml) Inhibition (%) IC50(μg/ml)
Standard 50 μg 47.54 ± 0.183⁎⁎ 52.58 μg
100 μg 54.67 ± 0.360⁎⁎
150 μg 58.54 ± 0.601⁎⁎
200 μg 62.45 ± 0.824⁎⁎
250 μg 68.06 ± 0.496⁎⁎
Chloroform extract 50 μg 30.86 ± 0.316⁎⁎ 261.94 μg
100 μg 38.26 ± 0.425⁎⁎
150 μg 41.62 ± 0.450⁎⁎
200 μg 45.04 ± 0.349⁎⁎
250 μg 47.72 ± 0.180⁎⁎
Ethyl acetate extract 50 μg 22.27 ± 0.398⁎⁎ 314.54 μg
100 μg 28.90 ± 0.333⁎⁎
150 μg 32.73 ± 0.300⁎⁎
200 μg 34.77 ± 0.560⁎⁎
250 μg 39.74 ± 0.418⁎⁎
Methanol extract 50 μg 38.52 ± 0.250⁎⁎ 155.99 μg
100 μg 44.63 ± 0.537**
150 μg 48.08 ± 0.472⁎⁎
200 μg 53.54 ± 0.628⁎⁎
250 μg 58.20 ± 0.309⁎⁎
Ethanol extract 50 μg 37.95 ± 0.698⁎ 213.72 μg
100 μg 39.24 ± 0.894⁎
150 μg 41.60 ± 0.812⁎
200 μg 46.79 ± 0.326⁎
250 μg 50.62 ± 0.870⁎
Aqueous extract 50 μg 45.81 ± 0.847⁎⁎ 96.74 μg
100 μg 51.68 ± 1.409⁎⁎
150 μg 55.73 ± 0.606**
200 μg 62.00 ± 0.588⁎⁎
250 μg 67.08 ± 0.499⁎⁎
Results are expressed as Mean ± SE (n = 3); * signiﬁcant at the p b 0.01.
Correlation is signiﬁcant at the 0.01 level (2-tailed)⁎⁎
Correlation is signiﬁcant at the 0.05 level (2-tailed)⁎
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duke; Purabi et al., 2011; Ezhilan and Neelamegam, 2011;
Hemalatha and Padmini, 2011; Senthilkumar et al., 2011). However
no reports are available on the activities of some identiﬁed com-
pounds such as 3-undecene, tridecene, and octadecanal. So present
study is expected to help in the identifying antidiabetic activity of se-
lected crude extracts of Ximenia americana.
From an extensive literature review it was observed that Ximenia
americana is widely used as a popular substitute remedy in certain re-
gions of the Africa (Guinea, Ethiopia, Nigeria, Sudan) and in the Brazil.
The plant extracts, particularly aqueous andmethanolic, showed several
biological activities such as antimicrobial, pesticidal, analgesic, antipy-
retic, anticancer and antitrypanosomal among others (Magassouba
et al., 2007; Maikai et al., 2008a; Maikai et al., 2008b; Maikai et al.,
2009; Rezanka and Sigler, 2007; Siddaiah et al., 2009; Soro et al.,
2009; Voss et al., 2006). Previous studies from our laboratories also
showed aqueous and methanolic Ximenia americana leaf extracts were
potent antioxidant and anti-inﬂammatory agent (Arun et al., 2015).
Hence, the present study also supporting and provides a clear scientiﬁc
basis that X. americana can be a potent source for the novel medicines.
Antidiabetic activities of aqueous X. americana leaves extract reported
for the ﬁrst time showed its therapeutic potential to be used as a cost ef-
fective safe herbal antidiabetic agent (Grover et al., 2002). Accordingly,
these results encourage further studies on extracts and identify particu-
lar active chemical compounds responsible for the speciﬁc biological ac-
tivity in order to standardize the plant preparation for maximum
therapeutic beneﬁt to treat diabetes.
5. Conclusion
Traditional therapeutic plants are frequently used in rural parts,
since the availability of extravagant amount of medicinal plants in
those areas. Thus, treating diabetes mellitus with herbal derived
composites that are accessible and do not necessitate laborious0
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Fig. 7. Percentage of glucose uptake in yeast celpharmaceutical production seems extremely attractive. This is of great
importance to developing countries such as India. The existence of
phytochemcials diversities in X. americana showed broad spectrum of
diverse biological activities and industrial applications such as antioxi-
dant, anti-inﬂammatory, antiviral, antibacterial, antifungal, dietary nu-
trient, in perfume making and alcohol industry. These results of GC-
MS proﬁle can be used as pharmacognostical tool for the identiﬁcation
of novel drugs from Ximenia americana. Based on the results obtained
from different in vitro anti-diabetic assays, there is signiﬁcant difference
in anti-diabetic activity of different extracts evaluated. Aqueous extract
of X. americana leaves has shown signiﬁcant anti-diabetic activity inthanol
xtract
Aqueous
extract*
Standard
ptake in yeast cells
50µg
100µg
150µg
200µg
250µg
ls treated with Ximenia americana extracts.
211A.K. Shettar et al. / South African Journal of Botany 111 (2017) 202–211both assays compared to other extracts. The present study revealed that
aqueous extract exhibited signiﬁcant in vitro anti-diabetic activity. The
result also demonstrated thatX. americana plant can be exploited to dis-
cover the bioactive natural products which may serve in the
development of new pharmaceuticals. Further, puriﬁcation of the spe-
ciﬁc active constituents need to be carried out, that can be used for
the discovery of novel drugs to treat diabetes mellitus, a worldwide
epidemic disease.
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